Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)-Reference-Cited by-同舟云学术

Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)

Published:2015-07-23 Issue:2 Volume:71 Page:187-189
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Heaney Liam G,Djukanovic Ratko,Woodcock Ashley,Walker Samantha,Matthews John G,Pavord Ian D,Bradding Peter,Niven Robert,Brightling Chris E,Chaudhuri Rekha,Arron Joseph R,Choy David F,Cowan Douglas,Mansur Adel,Menzies-Gow Andrew,Adcock Ian,Chung Kian F,Corrigan Chris,Coyle Peter,Harrison Timothy,Johnston Sebastian,Howarth Peter,Lordan James,Sabroe Ian,Bigler Jeannette,Smith Dirk,Catley Matthew,May Richard,Pierre Lisa,Stevenson Chris,Crater Glenn,Keane Frank,Costello Richard W,Hudson Val,Supple David,Hardman Tim

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference5 articles.

1. Non-invasive biomarkers that predict treatment benefit from biologic therapies in asthma;Arron;Ann Am Thorac Soc,2013

2. Non-adherence in difficult asthma; time to take it seriously;Heaney;Thorax,2012

3. Frequent exacerbators—a distinct phenotype of severe asthma;Kupczyk;Clin Exp Allergy,2014

4. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial;Green;Lancet,2002

5. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils);Petsky;Thorax,2012

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers to clinical remission in severe asthma;Respiratory Research;2024-04-24

2. Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma;Frontiers in Immunology;2024-04-19

3. Biologics for severe asthma—Which, when and why?;Respirology;2023-05-24

4. Epithelium‐derived cystatin SN inhibits house dust mite protease activity in allergic asthma;Allergy;2023-04-20

5. Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2023-04